GSK

Welcome to the 'GSK' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'GSK'.

Latest blogosphere posts tagged “GSK”

• Shared services and BPO: How to achieve optimum in real time?

  
  Outsource Portfolio — Authority: 127
  When have you personally visited your bank for the last time? Three years ago? Or: you don’t remember it? Modern technology makes it possible: You can use different services, offered by parties located world-wide having the Internet access and telephone connection. And parties offering these services do not have ...
  14 hours ago

• (GSK) GlaxoSmithKline Reports Higher Revenues

  
  Stock Blog Hub — Authority: 165
  GlaxoSmithKline, plc ( GSK ) reported third quarter income of 92 cents per American Depository Share (ADS), 3 cents below the Zacks Consensus Estimate. The company reported earnings of 94 cents in the year-ago period. Third quarter 2009 revenue increased 3%, with growth being driven by strong performances in ...
  1 day ago

• (GSK) GlaxoSmithKline plc Has Their H1N1 Vaccine Approved

  
  Stock Blog Hub — Authority: 165
  GlaxoSmithKline plc ( GSK ) recently received approval from the U.S. Food and Drug Administration (FDA) for its unadjuvanted influenza A (H1N1) pandemic vaccine.  The FDA approved the supplemental biologics license application (sBLA), which was filed as a strain change supplement to Glaxo’s FluLaval seasonal flu ...
  1 day ago

• Court Dismisses Tafas Suit Against Rules; Leaves Lower Court Ruling Intact

  
  Patent Baristas — Authority: 489
  In the the Tafas v. Kappos lawsuit, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office David Kappos and the U.S. Patent and Trademark Office filed a joint motion for dismissal of the appeal and to vacate the judgment of the district court below ...
  2 days ago

• JUST IN: Federal Circuit Denies Vacatur in USPTO Rules Case

  
  IPWatchdog.com | Patents & Patent Law — Authority: 601
  Earlier today the Chief Judge Paul Michel of the United States Court of Appeals for the Federal Circuit issued an Order declaring the pending appeal of Dr. Tafas and GlaxoSmithKline moot due to the fact that USPTO Director David Kappos has withdrawn the rules. The Federal Circuit per Judge Michel, however, denied the ...
  2 days ago

• GSK - Imitrex: oh no, here comes trouble

  
  PharmaGossip — Authority: 492
  Roy Poses writes: Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favorable to a sponsors product were suppressed. [Tfeft-Hansen PC. Unpublished clinical trials of sumatriptan. Lancet 2009; 374: 1501-2. Link here .] ...
  2 days ago

• Xconomy Videos: Sirtris’ Westphal and Millennium’s Dunsire Talk Cures for Ills of Big Pharma

  
  Xconomy — Authority: 709
  Big Pharma , Life Sciences , ceos Ryan McBride wrote: There’s new a dynamic at work in Big Pharma’s acquisitions of biotech companies in Boston and elsewhere. Drug companies don’t only want to buy biotech firms to enhance their R&D pipelines, they want to bring the innovators behind the biotechs ...
  2 days ago

• Treximet – head off

  
  AdPharm Blog — Authority: 147
  93" height="125" /> Click on image for original file provided by AdPharm “My migraines are so excruciating I just want to take my head off.” Treximet is superior to the ingredient in Imitrex tablets at relieving migraine pain. Brand name: Treximet Generic name/category: sumatriptan and ...
  2 days ago

• FDA Delays Cadence Drug Review: BioBuzz

  
  TheStreet.com — Authority: 574
  IV Acetaminophen review pushed back to February 2010.
  2 days ago

• Analyst upgrades, downgrades and initiations: ARO, AZN, BNI, BRCD, HBC, MRK, TIF ...

  
  BloggingStocks — Authority: 659
  Filed under: Analyst reports , Analyst upgrades and downgrades , Analyst initiations Analyst upgrades: Goldman upgraded Aeropostale ( ARO ) to neutral from sell. The firm, which has a $34 target on the stock, cites the recent sell-off in shares for the upgrade. Janney Montgomery upgraded ...
  3 days ago

• Drug makers seek looser rules for online ads

  
  Boston Globe -- CD reviews — Authority: 201
  WASHINGTON - As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter, and other websites.
  4 days ago

• Swine FLU A H1N1: GSK signs agreement with the WHO to donate 50 million doses of vaccine to developing countries

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 151
  GlaxoSmithKline (GSK) today announced that it has signed an agreement with the World Health Organization (WHO) to donate 50 million doses of its adjuvanted pandemic H1N1 influenza vaccine to WHO for distribution to developing countries most in need. GSK is working with WHO and health authorities to prepare for ...
  6 days ago

• Agreement for donation of pandemic H1N1 vaccine signed

  
  First Blog for Indian Financial Market — Authority: 162
  10 November 2009 — GlaxoSmithKline(GSK) is to donate 50 million doses of pandemic H1N1 vaccine to WHO under an agreement signed at WHO headquarters in Geneva by the WHO Director-General, Dr Margaret Chan, and the Chief Executive Officer of GlaxoSmithKline, Mr Andrew Witty. Agreement for donation of pandemic H1N1 ...
  6 days ago

• (RX) Big Pharma and Biotech – Industry Outlook

  
  Stock Blog Hub — Authority: 165
  The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III catalysts. The next five years are expected to reflect a significant imbalance between new product introductions and patent ...
  6 days ago

• (SNTS) Santarus Incorporated Reports Strong Quarter

  
  Stock Blog Hub — Authority: 165
  Santarus, Inc. ( SNTS ) reported third-quarter earnings of 9 cents per share, surpassing the Zacks Consensus Estimate at a loss of 1 cent and the year-ago loss of 8 cents. Total revenues, consisting of net product sales, promotion revenues, and license and royalty revenues, came in at $39.5 million, up 22% from the ...
  6 days ago

• 
  NYT > Theater — Authority: 914
  
  6 days ago

• Doc Offers Top Hep C Drug Picks: BioBuzz

  
  TheStreet.com — Authority: 574
  Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.
  6 days ago

• Xoma Waffles on Timing of Drug Partnership: BioBuzz

  
  TheStreet.com — Authority: 574
  An expected deal for its diabetes drug may not happen until next year.
  6 days ago

• Ariad Upgraded, Xenoport Drug Delayed: BioBuzz

  
  TheStreet.com — Authority: 574
  Analysts sees upside in two Ariad drugs while FDA delays decision on Xenoport drug.
  6 days ago

• Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®)s

  
  Pharmainfo.net — Authority: 165
  GlaxoSmithKline (GSK) today announced the results from the clinical trial assessing Pandemrix™, GSK’s adjuvanted H1N1 pandemic influenza vaccine, administered at the same time as the annual seasonal influenza vaccine, Fluarix ®. Advertisement: read more
  1 week ago

Comments about GSK